These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 35211756)
21. Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption. Hwang YS; Lee SK; Park KK; Chung WY Oral Oncol; 2012 Jan; 48(1):40-8. PubMed ID: 21925926 [TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo. Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470 [TBL] [Abstract][Full Text] [Related]
23. CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion. Park J; Zhang X; Lee SK; Song NY; Son SH; Kim KR; Shim JH; Park KK; Chung WY J Clin Invest; 2019 Dec; 129(12):5381-5399. PubMed ID: 31487270 [TBL] [Abstract][Full Text] [Related]
24. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459 [TBL] [Abstract][Full Text] [Related]
25. The downregulation of IGFBP3 by TGF-β signaling in oral cancer contributes to the osteoclast differentiation. Park J; Jung MJ; Chung WY Biochem Biophys Res Commun; 2021 Jan; 534():381-386. PubMed ID: 33256984 [TBL] [Abstract][Full Text] [Related]
26. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma. Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484 [TBL] [Abstract][Full Text] [Related]
27. Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice. Pandruvada SN; Yuvaraj S; Liu X; Sundaram K; Shanmugarajan S; Ries WL; Norris JS; London SD; Reddy SV Int J Cancer; 2010 May; 126(10):2319-29. PubMed ID: 19816883 [TBL] [Abstract][Full Text] [Related]
29. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma. Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663 [TBL] [Abstract][Full Text] [Related]
30. Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma. Quan J; Du Q; Hou Y; Wang Z; Zhang J Oncol Rep; 2017 Aug; 38(2):850-858. PubMed ID: 28656299 [TBL] [Abstract][Full Text] [Related]
31. Dual roles of cellular communication network factor 6 (CCN6) in the invasion and metastasis of oral cancer cells to bone via binding to BMP2 and RANKL. Hochi H; Kubota S; Takigawa M; Nishida T Carcinogenesis; 2023 Dec; 44(8-9):695-707. PubMed ID: 37590989 [TBL] [Abstract][Full Text] [Related]
32. Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma. Takayama Y; Mori T; Nomura T; Shibahara T; Sakamoto M Int J Oncol; 2010 Jun; 36(6):1387-94. PubMed ID: 20428761 [TBL] [Abstract][Full Text] [Related]
33. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33. Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528 [TBL] [Abstract][Full Text] [Related]
34. High-mobility group box 1 induces bone destruction associated with advanced oral squamous cancer via RAGE and TLR4. Sakamoto Y; Okui T; Yoneda T; Ryumon S; Nakamura T; Kawai H; Kunisada Y; Ibaragi S; Masui M; Ono K; Obata K; Shimo T; Sasaki A Biochem Biophys Res Commun; 2020 Oct; 531(3):422-430. PubMed ID: 32800556 [TBL] [Abstract][Full Text] [Related]
35. The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma. An YZ; Cho E; Ling J; Zhang X BMC Cancer; 2020 Oct; 20(1):987. PubMed ID: 33046030 [TBL] [Abstract][Full Text] [Related]
36. Cancer‑associated fibroblast‑derived exosomal miR‑382‑5p promotes the migration and invasion of oral squamous cell carcinoma. Sun LP; Xu K; Cui J; Yuan DY; Zou B; Li J; Liu JL; Li KY; Meng Z; Zhang B Oncol Rep; 2019 Oct; 42(4):1319-1328. PubMed ID: 31364748 [TBL] [Abstract][Full Text] [Related]
37. The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma. Jimi E; Furuta H; Matsuo K; Tominaga K; Takahashi T; Nakanishi O Oral Dis; 2011 Jul; 17(5):462-8. PubMed ID: 21496184 [TBL] [Abstract][Full Text] [Related]
38. [Osteoclastic bone destruction and its regulating factors in oral squamous cell carcinoma]. Cui NH; Zhang W; Wang EB; Wei MJ; Guo CB; Yu GY Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 39(1):30-2. PubMed ID: 17304322 [TBL] [Abstract][Full Text] [Related]
39. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma. Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595 [TBL] [Abstract][Full Text] [Related]
40. Histologic, immunohistochemical, and in situ hybridization study of myxoid stroma in feline oral squamous cell carcinoma. Mineshige T; Tanaka Y; Watanabe K; Tagawa M; Tomihari M; Kobayashi Y J Vet Med Sci; 2024 Mar; 86(3):258-265. PubMed ID: 38233195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]